Cell Therapy Market Enters a New Era of InnovationThe Global Cell Therapy Market is valued at USD 11.21 Billion in 2022 and ...

The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, and now he can hear,” said one parent. By Gina Kolata We can’t let the most ...

Most hypotheses suggest that earlier forms of life had partial genetic codes and used fewer than 20 amino acids. To test ...

A new platform identifies which genes drive particle assembly to engineer cells that yield more potent delivery vehicles.

Scientists shared transcripts with The Times in which chatbots described how to assemble deadly pathogens and unleash them in public spaces. By Gabriel J.X. Dance The treatment, the first of its kind, ...

Antibiotic resistance is making bacterial infections harder to treat, demanding new therapeutic strategies. A new review ...

A new study published in Engineering provides mechanistic insights into live-cell glycocalyx engineering and supports the rational design of next-generation adoptive cell therapies (ACTs) against B ...

Enzymes called proteases act like molecular scissors for proteins in the body and play a role in therapies to stop viruses ...

When scientist J. Craig Venter and his team announced in 2010 that they had created the first cell controlled by a fully synthetic genome, it marked a turning point in how scientists think about life.

There is increased evidence that extracellular DNA (exDNA) - genetic material released from bacteria killed during the water ...

IDT played a pivotal role in manufacturing the personalized gene editing therapy given to baby KJ Muldoon to treat his rare ...

Conventional wisdom holds that lower cholesterol is better for heart health, but new Views & Comments in Engineering challenges this idea. A large ...